Next Article in Journal
One Year of Complete Clinical Response in a Metastatic Breast Cancer Patient Treated with a Combination of Lapatinib and Gemcitabine
Previous Article in Journal
Evaluation of Six Risk Factors for the Development of Bacteremia in Children with Cancer and Febrile Neutropenia
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre

The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(2), 6-12; https://doi.org/10.3747/co.v17i2.555
Submission received: 1 March 2010 / Revised: 2 March 2010 / Accepted: 10 March 2010 / Published: 1 April 2010

Abstract

Hepatocellular carcinoma (HCC) is an uncommon tumour, but its incidence is increasing in Canada and elsewhere. Currently, there are no Canadian recommendations for diagnosis and treatment of HCC, and possible options may have regional limitations. A consensus symposium was held in the Ottawa region to consider current diagnostic and management options for HCC. These recommendations were developed: Diagnosis—with adequate imaging, a biopsy is not required pre-surgery, but is required before the start of systemic therapy; lesions smaller than 1 cm should be followed and not biopsied; repeat biopsies should be core tissue biopsies; magnetic resonance imaging is preferred, but triphasic computed tomography imaging can be useful Resection—recommended for localized hcc Radiofrequency ablation—recommended for unresectable or non-transplantable HCC; should not be performed in the presence of ascites Trans-arterial chemoembolization (TACE)—doxorubicin with lipiodol is the agent of choice; trans-catheter embolization is an alternative for patients if tace is not tolerated or is contraindicated Medical management—first-line sorafenib should be considered the standard of care Transplantation—suitable patients meeting Milan criteria should be assessed for a graft regardless of other treatments offered. The authors feel that the recommendations from this consensus symposium may be of interest to other regions in Canada.
Keywords: HCC; hepatoma; treatment; regional consensus guideline HCC; hepatoma; treatment; regional consensus guideline

Share and Cite

MDPI and ACS Style

Asmis, T.; Balaa, F.; Scully, L.; Papadatos, D.; Marginean, C.; Fasih, N.; Shaw–Stiffel, T.; Goel, R. Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre. Curr. Oncol. 2010, 17, 6-12. https://doi.org/10.3747/co.v17i2.555

AMA Style

Asmis T, Balaa F, Scully L, Papadatos D, Marginean C, Fasih N, Shaw–Stiffel T, Goel R. Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre. Current Oncology. 2010; 17(2):6-12. https://doi.org/10.3747/co.v17i2.555

Chicago/Turabian Style

Asmis, T., F. Balaa, L. Scully, D. Papadatos, C. Marginean, N. Fasih, T. Shaw–Stiffel, and R. Goel. 2010. "Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre" Current Oncology 17, no. 2: 6-12. https://doi.org/10.3747/co.v17i2.555

APA Style

Asmis, T., Balaa, F., Scully, L., Papadatos, D., Marginean, C., Fasih, N., Shaw–Stiffel, T., & Goel, R. (2010). Diagnosis and Management of Hepatocellular Carcinoma: Results of a Consensus Meeting of The Ottawa Hospital Cancer Centre. Current Oncology, 17(2), 6-12. https://doi.org/10.3747/co.v17i2.555

Article Metrics

Back to TopTop